150 related articles for article (PubMed ID: 30938551)
1. Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study.
Eguchi K; Iwanaga M; Terada K; Aramaki T; Tuji Y; Kurushima S; Kojima K; Arima K; Iwamoto N; Ichinose K; Kawakami A; Hirakata N; Ueki Y
Mod Rheumatol; 2020 May; 30(3):471-480. PubMed ID: 30938551
[No Abstract] [Full Text] [Related]
2. The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study.
Iwamoto N; Araki T; Umetsu A; Takatani A; Aramaki T; Ichinose K; Terada K; Hirakata N; Ueki Y; Kawakami A; Eguchi K
Front Immunol; 2022; 13():887783. PubMed ID: 35603142
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
4. The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Umekita K; Hashiba Y; Kariya Y; Kubo K; Miyauchi S; Aizawa A; Umeki K; Nomura H; Kawaguchi T; Matsuda M; Takajo I; Hidaka T; Okayama A
Mod Rheumatol; 2019 Sep; 29(5):795-801. PubMed ID: 30246572
[No Abstract] [Full Text] [Related]
5. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.
Iwanaga M; Watanabe T; Utsunomiya A; Okayama A; Uchimaru K; Koh KR; Ogata M; Kikuchi H; Sagara Y; Uozumi K; Mochizuki M; Tsukasaki K; Saburi Y; Yamamura M; Tanaka J; Moriuchi Y; Hino S; Kamihira S; Yamaguchi K;
Blood; 2010 Aug; 116(8):1211-9. PubMed ID: 20448111
[TBL] [Abstract][Full Text] [Related]
6. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease.
Yakova M; Lézin A; Dantin F; Lagathu G; Olindo S; Jean-Baptiste G; Arfi S; Césaire R
Retrovirology; 2005 Feb; 2():4. PubMed ID: 15686595
[TBL] [Abstract][Full Text] [Related]
7. Analysis of HTLV-1 proviral load (PVL) and antibody detected with various kinds of tests in Japanese blood donors to understand the relationship between PVL and antibody level and to gain insights toward better antibody testing.
Matsumoto C; Sagara Y; Sobata R; Inoue Y; Morita M; Uchida S; Kiyokawa H; Satake M; Tadokoro K
J Med Virol; 2017 Aug; 89(8):1469-1476. PubMed ID: 28252206
[TBL] [Abstract][Full Text] [Related]
8. Evaluating mRNA expression of tax, B chain of PDGF and PDGF-β receptors as well as HTLV-I proviral load in ATL patients and healthy carriers.
Atabati H; Esmaeili SA; Allahyari A; Shirdel A; Rahimi H; Rezaee SA; Momtazi-Borojeni AA; Rafatpanah H
J Med Virol; 2021 Jun; 93(6):3865-3870. PubMed ID: 32918495
[TBL] [Abstract][Full Text] [Related]
9. HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study.
Umekita K; Hashikura Y; Takaki A; Kimura M; Kawano K; Iwao C; Miyauchi S; Kawaguchi T; Matsuda M; Hashiba Y; Hidaka T
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851682
[TBL] [Abstract][Full Text] [Related]
10. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases.
Demontis MA; Hilburn S; Taylor GP
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):359-64. PubMed ID: 22894552
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1 proviral load in infective dermatitis associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission.
Batista ES; Oliveira PD; Primo J; Varandas CMN; Nunes AP; Bittencourt AL; Farre L
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007705. PubMed ID: 31851683
[TBL] [Abstract][Full Text] [Related]
12. Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.
Einsiedel L; Pham H; Wilson K; Walley R; Turpin J; Bangham C; Gessain A; Woodman RJ
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006281. PubMed ID: 29529032
[TBL] [Abstract][Full Text] [Related]
13. Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.
Ueno S; Umeki K; Takajo I; Nagatomo Y; Kusumoto N; Umekita K; Morishita K; Okayama A
Int J Cancer; 2012 May; 130(10):2318-26. PubMed ID: 21780105
[TBL] [Abstract][Full Text] [Related]
14. Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early.
Wolf SN; Haddow J; Greiller C; Taylor GP; Cook LBM; Rowan AG
Blood Cancer J; 2021 Mar; 11(3):66. PubMed ID: 33771974
[TBL] [Abstract][Full Text] [Related]
15. Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers.
Neto WK; Da-Costa AC; de Oliveira AC; Martinez VP; Nukui Y; Sabino EC; Sanabani SS
Virol J; 2011 Dec; 8():535. PubMed ID: 22166003
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
Lee TH; Chafets DM; Busch MP; Murphy EL
J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269
[TBL] [Abstract][Full Text] [Related]
17. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
18. Evolution of HTLV-1 proviral load in patients from Salvador, Brazil.
Olavarria VN; Gomes Ado N; Kruschewsky Rde A; Galvão-Castro B; Grassi MF
Braz J Infect Dis; 2012; 16(4):357-60. PubMed ID: 22846124
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
[TBL] [Abstract][Full Text] [Related]
20. Multiplex Droplet Digital PCR Assay for Quantification of Human T-Cell Leukemia Virus Type 1 Subtype c DNA Proviral Load and T Cells from Blood and Respiratory Exudates Sampled in a Remote Setting.
Yurick D; Khoury G; Clemens B; Loh L; Pham H; Kedzierska K; Einsiedel L; Purcell D
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30518541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
